Secure your seat in Jobbyist Africa for $250 per seat, or SkinLabs® South Africa for $125 per seat, via a single pooled Special Purpose Vehicle. Early-stage equity with real governance protections — not just a wire transfer and a promise.
The Opportunity
Founding Members choose their preferred asset — or both. Your contribution is pooled through a single SPV that holds equity in each subsidiary on behalf of all ten members.
An AI-assisted job discovery and career management platform for African professionals — CV optimisation, application tracking, and intelligent job matching, launching in South Africa in July 2026.
| Metric | Year 1 | Year 2 | Year 3 |
|---|---|---|---|
| Registered users | 15,000 | 65,000 | 180,000 |
| Annual revenue | R480k | R2.1m | R6.8m |
| Implied valuation | $83.3k | ~$250k | ~$650k |
Illustrative growth scenario only — not a forecast or guarantee. See the Investment Memorandum for full assumptions and risk factors.
An AI-powered skin diagnostics and personalised skincare platform — matching users to formulations using computer-vision skin analysis, with a direct-to-consumer product line in development.
| Metric | Year 1 | Year 2 | Year 3 |
|---|---|---|---|
| Customers served | 3,000 | 12,000 | 30,000 |
| Annual revenue | R950k | R4.2m | R11.5m |
| Implied valuation | $25k | ~$90k | ~$220k |
Illustrative growth scenario only — not a forecast or guarantee. See the Investment Memorandum for full assumptions and risk factors.
A Special Purpose Vehicle lets ten separate contributions behave as a single, clean line on each subsidiary's cap table — better for you, and better for the companies you're backing.
Jobbyist and SkinLabs deal with a single nominee shareholder, not ten separate cap-table entries. Cleaner governance for the companies, more negotiating weight for you.
Your exposure is ring-fenced to the asset(s) you choose. A member who backs SkinLabs only carries no economic exposure to Jobbyist's outcome, and vice versa — tracked internally within the SPV.
Why Founding Members?
Every protection below is written into the subscription and shareholder documentation you receive after your NDA is signed — not left to a handshake.
Unlike founder or employee equity, your Founding Member allocation vests 100% on execution of your subscription agreement and receipt of funds. No cliff, no waiting period to "earn" what you've already paid for.
The ten of you form an internal quorum. Major decisions are put to a majority vote among Founding Members before the SPV's nominee casts a single, unified vote at the subsidiary level.
The SPV's stake carries broad-based, weighted-average anti-dilution protection in any future down round, subject to standard carve-outs such as option-pool top-ups.
If and when either subsidiary declares a dividend, your pro-rata share is passed through the SPV to you directly — no discretionary withholding beyond standard admin timing.
Before any future priced round is opened to outside investors, the SPV — on your behalf — has the first right to invest enough to maintain its existing ownership percentage.
Founder and key-team equity at both subsidiaries remains subject to standard multi-year vesting — so the people building Jobbyist and SkinLabs stay incentivised for the long haul, not just the raise.
Governance & Structure
Ten equal contributions, one legal vehicle, two subsidiary stakes. No layers you can't explain to your accountant in one sentence.
Each Founding Member's economic interest in the SPV is calculated strictly pro-rata to their contribution — no preferential terms for any single seat.
The nominee representative holds legal title on the cap table and executes instructions from the Founding Member quorum — they do not have independent discretion over your equity.
Projections & Traction
Conservative and growth scenarios for each asset over three years. These are illustrative planning figures drawn from the Investment Memorandum, not commitments.
| Jobbyist Africa — Revenue Scenario (ZAR) | |||
|---|---|---|---|
| Conservative base case | Y1: R320k | Y2: R1.1m | Y3: R3.4m |
| Growth upside | Y1: R480k | Y2: R2.1m | Y3: R6.8m |
| SkinLabs® SA — Revenue Scenario (ZAR) | |||
|---|---|---|---|
| Conservative base case | Y1: R620k | Y2: R2.3m | Y3: R6.1m |
| Growth upside | Y1: R950k | Y2: R4.2m | Y3: R11.5m |
Figures are illustrative planning scenarios prepared for the Founding Members Programme and are not audited forecasts. Actual results may differ materially. Full methodology and assumptions are set out in the Investment Memorandum.
“We built Gravitas Industries on a simple belief: that Africa's next generation of category-defining companies won't come from copying Silicon Valley, but from solving distinctly African problems with world-class technology. Jobbyist and SkinLabs are two early proof points of that thesis. The Founding Members Programme exists so a small, deliberate group of people can back that belief with us from day one — with real governance, not just a good story.
Compliance & Process
Fully compliant with the South African Companies Act, 71 of 2008. Every step below produces a document you keep.
Complete the application form with your details and preferred asset(s). We confirm you meet the eligibility criteria before documents are issued.
Digitally e-sign the Non-Disclosure Agreement and Indemnity Form directly in the application flow. Both are also available as downloadable PDFs for your records.
The confidential Founding Members Charter, Equity Governance Protocol, and supporting subscription documents are sent to your inbox, along with a secure link to pay your fixed bid amount.
Pay your fixed bid — $250 for Jobbyist, $125 for SkinLabs, or $375 for both — via the secure payment link. Funds are held pending SPV registration.
The Gravitas Founding Members SPV is registered with the Companies and Intellectual Property Commission and formally takes its equity position in each subsidiary.
You receive confirmation of your pro-rata interest in the SPV, your signed agreements, and your place in the Founding Members reporting cycle.
FAQ
A pro-rata economic interest in the Gravitas Founding Members SPV, which in turn holds a 3% stake in Jobbyist Africa and/or a 5% stake in SkinLabs® South Africa depending on which asset(s) you select. You are not buying shares directly in either subsidiary — the SPV is the single shareholder of record.
This is speculative, early-stage equity in two pre-scale companies. Either or both may fail, and you could lose your entire contribution. No return, dividend, exit, liquidity event, or valuation increase is guaranteed or implied. This is why the indemnity form and full risk disclosures in the Investment Memorandum are mandatory reading before you bid.
No. Vesting schedules apply to compensation-based equity for founders and employees, who need to stay to earn it. As an investor, your allocation vests 100% immediately once your subscription agreement is executed and funds are received — there's nothing further to wait out.
Realistic exit paths for early-stage equity like this are a trade sale of the subsidiary, a later priced round where existing investors can sell a portion, or (in the best case) an eventual acquisition. There is no guaranteed liquidity window, no redemption right, and no secondary market — treat this as illiquid capital for the foreseeable future.
$125 for a SkinLabs-only seat, $250 for a Jobbyist-only seat, or $375 to hold a seat in both. There is no way to purchase a partial or fractional seat — the bid amounts are fixed and identical for every Founding Member choosing the same asset(s).
Yes. Select both in the application form for a combined $375 bid. You'll hold a pro-rata interest in both underlying stakes through the same SPV, with your exposure to each tracked and ring-fenced separately.
No. This is the point of risk isolation within the pooled SPV. Your economic interest and any loss are limited to the asset(s) you selected and funded — you carry no exposure to the other subsidiary's performance simply by being part of the same SPV.
You vote internally, alongside the other nine Founding Members, on major matters affecting the SPV's position (such as participation in a future round, or a material corporate action at either subsidiary). Once a majority position is reached, the nominee representative casts one unified vote on the subsidiary's cap table — you do not vote directly at the subsidiary level.
The SPV's stake carries broad-based, weighted-average anti-dilution protection in a future down round, and pre-emptive rights to participate in future priced rounds to maintain its ownership percentage. Neither protection is a guarantee against dilution in every scenario — full mechanics are set out in the shareholder agreement.
Only if and when either subsidiary's board declares one — which is unlikely in the early years, since early-stage companies typically reinvest revenue into growth rather than distribute it. If a dividend is declared, your pro-rata share is passed through the SPV to you.
Tax treatment depends on your country of residence, entity type, and personal circumstances, and this page is not tax advice. South African tax residents should consider the Income Tax Act implications of equity acquisition, potential future dividends, and capital gains on disposal. International Founding Members must also consider their home jurisdiction's treatment of foreign equity holdings. Please consult an independent tax advisor before subscribing.
The SPV will be registered with the CIPC in accordance with the South African Companies Act, 71 of 2008. This programme is a private offering to a limited, defined group of 10 Founding Members — it is not a public offer or prospectus. It is each applicant's responsibility to ensure participation is lawful in their own jurisdiction; we reserve the right to decline applications where this cannot be confirmed.
The Founding Members Programme is strictly capped at 10 seats and closes permanently once filled — there is no waitlist for this cohort. Future Gravitas Industries fundraising rounds, if any, will be communicated separately and are not guaranteed to offer the same terms.
Email partners@gravitas.uno for programme questions, or read the full Investment Memorandum for complete terms and risk disclosures before applying.
Limited to 10 seats
Applications are reviewed on a rolling basis. Once all 10 seats are funded, the programme closes for this cohort — there is no second allocation at these terms.
The Founding Members Programme does not constitute a public offer, prospectus, solicitation, financial advice, tax advice or legal advice in any jurisdiction.
Any investment is speculative and high risk. Early-stage startups may fail and investors may lose all invested capital. No return, dividend, exit, liquidity event, valuation increase, or future fundraising success is guaranteed or implied.
All Founding Members must sign an NDA and indemnity form before their bid is accepted. All final terms are subject to signed legal documentation, applicable board and shareholder approvals, accounting review, and compliance with South African company law and applicable securities, exchange control, consumer protection, privacy and fundraising regulations.
ZAR amounts use a planning rate of USD 1 = ZAR 16.50; final amounts use the agreed spot rate on the signing date. Please seek independent legal, financial and tax advice before subscribing. See the full Investment Memorandum on our website for complete legal disclosures, or view our Terms & Conditions.
The Founding Members Programme does not constitute a public offer, prospectus, solicitation, financial advice, tax advice or legal advice in any jurisdiction. It is a private offering limited to 10 participants.
Any investment is speculative and high risk. Early-stage startups may fail and investors may lose all invested capital. No return, dividend, exit, liquidity event, valuation increase, or future fundraising success is guaranteed or implied.
All Founding Members must sign an NDA and indemnity form before their bid is accepted. Full agreements are issued after application review.
All final terms are subject to signed legal documentation, applicable board and shareholder approvals, accounting review, and compliance with South African company law and applicable securities, exchange control, consumer protection, privacy and fundraising regulations.
ZAR amounts use a planning rate of USD 1 = ZAR 16.50; final amounts use the agreed spot rate on the signing date.
Please seek independent legal, financial and tax advice before subscribing. See the full Investment Memorandum for complete legal disclosures.